Clinical trial
GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the…
NCT00376272 · Gruppo di Ricerca GISSI, Other · Completed
Key facts
| NCT number | NCT00376272 |
|---|---|
| Title | GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence |
| Official title | Randomized, Prospective, Parallel Group, Placebo-Controlled, Multi-Center Study on the Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence |
| Lead sponsor | Gruppo di Ricerca GISSI, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation |
| Intervention type | Drug |
| Interventions | Valsartan, Placebo |
| Enrollment | 1,442 |
| Start date | Nov 1, 2004 |
| Primary completion | Jan 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Sep 14, 2006 |
| Last update posted | Apr 20, 2009 |
| Countries | Italy, Switzerland |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: